French evaluation of conditions for the systematic implementation of leucocyte removal in labile blood products (LBP).
Chamfly
V
V
NBA, France.
D001771:Blood Banks / Q000191:economics / Q000592:standards / Q000706:statistics & numerical data; D016913:Blood Component Transfusion / Q000191:economics / Q000295:instrumentation / Q000379:methods / Q000592:standards*; D002469:Cell Separation / Q000295:instrumentation / Q000379:methods; D002498:Centrifugation; D003625:Data Collection; D017707:Erythrocyte Transfusion; D005374:Filtration / Q000295:instrumentation; D005602:France; D006291:Health Policy; D006801:Humans; D007962:Leukocytes / Q000821:virology; D017713:Platelet Transfusion; D011786:Quality Control; D012449:Safety; D065227:Transfusion Reaction; D014777:Virus Diseases / Q000517:prevention & control / Q000635:transmission; D000094902:Blood Banking / Q000379:methods